-
A Review of the Three Chinese Patent Medicines Affirmed by China to Treat COVID-19
Miling
April 30, 2020
A Review of the Three Chinese Patent Medicines Affirmed by the National Administration of Traditional Chinese Medicine of China to Treat COVID-19
-
Pneumagen Announces Results from COVID-19 Infection Prevention Study
americanpharmaceuticalreview
April 29, 2020
Pneumagen announced results from three separate in vitro studies into preventing coronavirus infections including SARS-CoV-2 infection.
-
Syngene International converts lab into COVID-19 RT-PCR testing centre
expresspharma
April 29, 2020
A team of scientists has been trained to perform these tests as per the guidelines prescribed by national and global regulatory authorities.
-
Global manufacturing “fundamental” for drug supply chain, says ABPI Chief Executive
europeanpharmaceuticalreview
April 29, 2020
The ABPI’s Dr Richard Torbett, speaking to the International Trade Committee, said the COVID-19 pandemic highlights the need for a globalised drug supply chain.
-
Merck and Institute for Systems Biology Enter COVID-19 Collaboration
contractpharma
April 29, 2020
To define molecular mechanisms of SARS-CoV-2 infection and identify potential prognostic biomarkers.
-
LabVantage Launches Biobanking LIMS Accelerator for Managing COVID-19 Testing
contractpharma
April 29, 2020
LabVantage Solutions, Inc., a provider of laboratory informatics solutions and services, has announced the availability of its purpose-built COVID-19 LIMS solution.
-
Gujarat to try Ayurvedic drugs on select COVID-19 patients
expresspharma
April 29, 2020
75 patients will be given Ayurvedic medicines like Samshamni Vati, Dasmool Kvath, Trikatu Churna.
-
Shiv Nadar University develops molecule with potential to cure COVID-19
expresspharma
April 29, 2020
The molecule has the potential to be developed into a drug that can cure Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients, animal trials to begin soon as a prelude to human trials.
-
Genalyte Launches High-Speed COVID-19 Antibody Test
contractpharma
April 29, 2020
First instrument-based, rapid test uses multi-antigen approach; U.S. FDA EUA submitted.
-
Novartis sales, profits rise in first quarter on COVID-19 buying rush
expresspharma
April 29, 2020
The result topped Novartis’s 2020 forecast of mid to high single-digit percentage growth for revenue and high single-digit to low double-digit growth for operating profit.